Study guide
10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis
Key Takeaways Explain This Topic AI
Perinatal Mood and Anxiety Disorders (PMADs) span a clinical spectrum from benign Postpartum Blues (50–80% incidence; onset day 2–3, resolving spontaneously by day 10–14) to Postpartum Depression (10–15% incidence; persistent sadness, anhedonia, insomnia, lasting >2 weeks).
Universal screening utilizes the 10-item Edinburgh Postnatal Depression Scale (EPDS); an EPDS score ≥10 indicates elevated risk (≥13 indicates likely major depression), while ANY positive score (>0) on Question 10 (self-harm ideation) mandates an immediate, mandatory face-to-face suicide safety assessment before discharge.
Sertraline (Zoloft) is the preferred first-line SSRI for lactating individuals due to exceptionally high protein binding and minimal breast milk penetration (Relative Infant Dose <2%); novel GABA-A receptor neuroactive steroids include oral Zuranolone (14-day course) and IV Brexanolone (60-hour infusion requiring REMS pulse oximetry monitoring).
Postpartum Psychosis (PPP; 1–2 per 1,000 births) is an acute psychiatric emergency presenting with infant-centered delusions, hallucinations, and rapid mood lability, carrying a 4% infanticide and 5% suicide risk.
Immediate clinical management of postpartum psychosis requires safe, supervised separation of the infant from the mother, initiation of continuous 1:1 safety observation, emergency psychiatric evaluation for inpatient hospitalization, and initiation of mood stabilizers and second-generation antipsychotics.
Last updated: August 2026
Neuroendocrine Pathophysiology & The Spectrum of PMADs
Perinatal Mood and Anxiety Disorders (PMADs) are recognized as the single most common clinical complication of childbirth, surpassing gestational diabetes and preeclampsia in total incidence. Maternal suicide and substance overdose associated with unaddressed mental health disorders account for over 20% of all pregnancy-related deaths in the United States, representing a primary cause of late maternal mortality.
Neuroendocrine Withdrawal Hypothesis
During pregnancy, circulating levels of estradiol and progesterone rise over 100-fold above non-pregnant baseline levels. Concurrently, levels of allopregnanolone (a potent neuroactive progesterone metabolite that acts as a positive allosteric modulator of inhibitory GABA A \text{GABA}_\text{A} GABA A receptors in the central nervous system) surge to supraphysiological concentrations, enhancing neural calming and stress resilience. +---------------------------------------------------------------------------------------------------+
- | NEUROENDOCRINE SHIFT & PMAD PATHOPHYSIOLOGY |
- +---------------------------------------------------------------------------------------------------+
- │
- [ DELIVERY OF PLACENTA ]
- │
- ▼
- [ Precipitous Drop in Estrogen & Progesterone (>95% drop in 48h) ]
- [ Sudden Elimination of Allopregnanolone Synthesis ]
- │
- ▼
- [ Downregulation of GABA-A Receptor Sensitivity ]
- Uncoupling of neural inhibitory pathways
- Dysregulation of Hypothalamic-Pituitary-Adrenal (HPA) axis
- Alterations in central Serotonin (5-HT) and Dopamine signaling
- Severe sleep deprivation & circadian disruption
- │
- ┌─────────────────────────────┼─────────────────────────────┐
- ▼ ▼ ▼
- [ POSTPARTUM BLUES ] [ POSTPARTUM DEPRESSION ] [ POSTPARTUM PSYCHOSIS ]
- 50-80% of women • 10-15% of women • 0.1-0.2% (1-2 per 1,000)
- Day 2-3 to Day 10-14 • Onset 2-6 wks (up to 1 yr) • Rapid onset Day 3-14
- Transient / Self-limiting • Persistent >2 weeks • Delusions / Hallucinations
- Reassurance & rest • EPDS >=10-13 / SSRI therapy • Psychiatric Emergency
- Differential Diagnosis Across the Perinatal Mood Spectrum
Accurate clinical differentiation between transient emotional adaptation, unremitting depression, intrusive anxiety disorders, and acute psychosis is essential for patient safety and targeted intervention:
Diagnostic Category Prevalence & Peak Onset Hallmark Clinical Symptoms Impact on Functioning & Attachment Clinical Management & Nursing Care
Postpartum Blues (Baby Blues) 50%–80% ; Onset: Days 2–3; Peak: Days 4–5; Resolves: By Day 10–14 Mild tearfulness, emotional lability, irritability, fatigue, anxiety, insomnia, mild mood swings. No functional impairment. Patient provides excellent infant care and maintains strong maternal bonding. Anticipatory guidance, emotional validation, rest/sleep support, family partner assistance. Monitor for progression to PPD.
Postpartum Depression (PPD) 10%–15% ; Onset: 2–6 weeks (up to 12 months postpartum) Unremitting sadness, severe anhedonia, excessive guilt, worthlessness, panic, sleep disturbance (unable to sleep when baby sleeps), suicidal ideation. Moderate to severe functional impairment. Emotional detachment, flat affect with infant, difficulty responding to infant cues. Psychotherapy (CBT/IPT), First-line SSRIs (Sertraline) , Zuranolone, Brexanolone, structured support groups.
Postpartum Anxiety & OCD 8%–12% ; Onset: 2–8 weeks postpartum Constant agonizing worry, panic attacks, motor restlessness, egodystonic intrusive thoughts (fears of accidental harm to baby, dropping baby). Avoidant behaviors (avoids bathing baby, avoids knives/stairs), compulsive checking of infant breathing. Patient recognizes thoughts are irrational/horrifying (egodystonic). Reassurance, CBT, SSRIs. Must differentiate from psychosis.
Postpartum Psychosis (PPP) 0.1%–0.2% (1–2 / 1,000); Onset: Days 3–14 (up to 4 weeks) Bizarre delusions (baby is possessed, cursed, or evil), auditory/visual hallucinations, delirium, severe confusion, paranoia, mania, suicidal/infanticidal intent. Catastrophic impairment. Complete loss of reality testing. High lethality (4% infanticide, 5% suicide risk). EMERGENCY HOSPITALIZATION. Supervised physical separation from infant, antipsychotics, mood stabilizers (Lithium), ECT.
Critical Distinction: Egodystonic Intrusive Thoughts vs. Egosyntonic Psychotic Delusions
Postpartum OCD / Anxiety (Egodystonic): The mother experiences horrific, intrusive thoughts of harm coming to the infant (e.g., "What if I accidentally drop the baby down the stairs?"). These thoughts cause intense distress, horror, guilt, and terror . The mother recognizes these thoughts as irrational and repellent and adopts avoidance behaviors to protect the infant. There is NO loss of reality testing , and the risk of intentional harm is virtually zero.
Postpartum Psychosis (Egosyntonic): The mother harbors delusional beliefs that she accepts as absolute truth (e.g., "God is telling me that my baby is a demon and must be sacrificed to save the world"). The mother is not distressed by the irrationality of the thought because her reality testing is destroyed . This represents an immediate, life-threatening emergency requiring urgent protective separation.
Screening Protocols: The Edinburgh Postnatal Depression Scale (EPDS)
The Edinburgh Postnatal Depression Scale (EPDS) is a universally validated, 10-item self-report screening questionnaire designed to evaluate perinatal depressive symptoms over the preceding 7 days without confounding somatic symptoms of normal postpartum recovery (such as fatigue, appetite changes, or sleep disruption). +---------------------------------------------------------------------------------------------------+
- | EDINBURGH POSTNATAL DEPRESSION SCALE (EPDS) MATRIX |
- +---------------------------------------------------------------------------------------------------+
- [ TOTAL EPDS SCORE RANGE: 0 TO 30 POINTS ]
- │
- ┌─────────────────────────────┼─────────────────────────────┐
- ▼ ▼ ▼
- [ SCORE: 0 TO 9 POINTS ] [ SCORE: 10 TO 12 POINTS ] [ SCORE: >=13 POINTS ]
- Low risk for depression • High risk / Borderline PPD • Positive screen for PPD
- Routine postpartum support • Comprehensive clinical eval • Diagnostic psychiatric evaluation
- Repeat screen at 6 weeks • Close outpatient follow-up • Initiate psychotherapy & SSRIs
- │
- ▼
- [ CRITICAL SAFETY TRIGGER: QUESTION 10 (EVALUATION OF SELF-HARM) ]
- Question 10 asks: "The thought of harming myself has occurred to me."
Options: Never (0), Hardly ever (1), Sometimes (2), Yes, quite often (3).
• ANY NON-ZERO SCORE (Score of 1, 2, or 3) ON QUESTION 10 CONSTITUTES AN AUTOMATIC EMERGENCY TRIGGER!
- Nursing Mandate: The nurse must NEVER permit the patient to leave the facility until an immediate,
- face-to-face suicide risk assessment and lethal means safety plan are completed by a licensed
mental health clinician or psychiatrist.
Pharmacotherapy & Advanced Therapeutics for PPD +---------------------------------------------------------------------------------------------------+
- | PHARMACOTHERAPY FOR POSTPARTUM DEPRESSION |
- +---------------------------------------------------------------------------------------------------+
THERAPEUTIC CLASS DRUG & DOSING BREASTFEEDING SAFETY CLINICAL HIGHLIGHTS & MECHANISM
------------------- ------------------------------- ---------------------- --------------------------------------------------
Selective Serotonin SERTRALINE (Zoloft) FIRST-LINE SSRI CHOICE • Lowest excretion into breast milk (Relative
Reuptake Inhibitors • Dose: 25-50 mg PO daily, (Infant serum levels Infant Dose [RID] <1-2%).
(SSRIs) titrated up to 150-200 mg/day are undetectable) • Well-tolerated; onset of therapeutic antidepressant
benefit takes 2 to 4 weeks.
------------------------------- ---------------------- --------------------------------------------------
PAROXETINE (Paxil) SAFE IN LACTATION • Low breast milk transfer.
• Dose: 10-20 mg PO daily (Very low RID) • Note: Avoid in antepartum if possible due to
slight risk of fetal cardiac malformations.
- ------------------------------ ---------------------- --------------------------------------------------
- CITALOPRAM / ESCITALOPRAM COMPATIBLE • Slightly higher milk levels than sertraline;
• Dose: 10-20 mg PO daily monitor infant for excessive somnolence.
------------------- ------------------------------- ---------------------- --------------------------------------------------
Serotonin-NE VENLAFAXINE (Effexor XR) COMPATIBLE • Excellent for severe depression with comorbid
Reuptake Inhibitors • Dose: 37.5-75 mg PO daily generalized anxiety disorder.
------------------- ------------------------------- ---------------------- --------------------------------------------------
GABA-A Receptor BREXANOLONE (Zulresso) SAFETY EVALUATED • First FDA-approved drug specifically for PPD.
Positive Modulators • Route: Continuous 60-hour IV (Low RID) • Synthetic allopregnanolone; provides rapid
(Neuroactive infusion (weight-based titration) relief of severe PPD within 24 to 48 hours.
Steroids) • BLACK BOX WARNING: REMS program required.
- High risk of sudden loss of consciousness
- and excessive sedation. Requires continuous
pulse oximetry and dedicated bedside companion.
------------------------------- ---------------------- --------------------------------------------------
ZURANOLONE (Zurzuvae) COMPATIBLE • First ORAL neuroactive steroid for PPD.
• Dose: 50 mg PO daily in the (Low RID) • Rapid 14-day daily treatment course taken in
evening with a fatty meal the evening with food.
for exactly 14 days • Rapid antidepressant response within 3 to 7 days.
• Causes CNS depression/somnolence; warn patient
not to drive for 12 hours after each dose.
- +---------------------------------------------------------------------------------------------------+
- Emergency Inpatient Management of Postpartum Psychosis (PPP)
Postpartum Psychosis is a psychiatric emergency with a rapid, unpredictable trajectory. Approximately 50% of women who develop PPP have no prior psychiatric history, while women with pre-existing Bipolar Disorder (Type I or II) or previous postpartum psychosis carry a catastrophic recurrence risk of 25% to 50% . +---------------------------------------------------------------------------------------------------+
- | EMERGENCY MANAGEMENT PROTOCOL FOR POSTPARTUM PSYCHOSIS |
- +---------------------------------------------------------------------------------------------------+
[ STEP 1: IMMEDIATE SAFETY & PROTECTIVE ISOLATION ]
- NEVER leave the mother alone with the infant under any circumstances!
- Place infant in nursery or with trusted family member under continuous supervision.
- Initiate 1:1 continuous safety observation for the mother (suicide & elopement precautions).
- Remove all sharp objects, cords, and hazardous items from the patient environment.
- │
- ▼
- [ STEP 2: MEDICAL & ORGANIC WORKUP ]
- Rule out secondary organic causes of delirium: obtain CBC, comprehensive metabolic panel,
- thyroid panel (TSH, free T4 for postpartum thyroiditis), urinalysis, urine drug screen,
and serum ammonia / autoimmune encephalopathy markers.
- │
- ▼
- [ STEP 3: PSYCHIATRIC HOSPITALIZATION & PHARMACOTHERAPY ]
• Arrange emergent involuntary or voluntary transfer to an inpatient psychiatric facility.
• Rapid Pharmacologic Stabilization:
a) Second-Generation Antipsychotics: Olanzapine (Zyprexa), Quetiapine (Seroquel), or Haloperidol.
b) Mood Stabilizers: Lithium Carbonate (first-line in bipolar postpartum psychosis).
c) Benzodiazepines: Lorazepam (Ativan) for severe agitation, catatonia, and insomnia.
• Electroconvulsive Therapy (ECT): Highly effective, rapid, safe modality for treatment-refractory
psychosis, severe catatonia, or acute severe suicidal/infanticidal crisis.